Experience Cutting-Edge Innovations From Around the World in Bangkok, Thailand, at TEP X OIIO ASIA TECHLAND 2023
BANGKOK, May 22, 2023 – (ACN Newswire) – The leading Thai Technology and Real Estate…
BANGKOK, May 22, 2023 – (ACN Newswire) – The leading Thai Technology and Real Estate…
The Power of GPT-3.5 AI Combined with AWS Brings Advanced Content Creation to the Fingertips…
Geneva, Switzerland, May 22, 2023 – (ACN Newswire) – The crucial topics of micronutrient deficiencies…
Astana, Kazakhstan, May 22, 2023 – (ACN Newswire) – RHT AlDigi Financial Holdings Pte. Ltd….
Online platform helps organize every medical insurance claim through one user-friendly dashboard PURCHASE, N.Y.–(BUSINESS WIRE)–Mastercard…
Company’s Partners Add System Integration and Solutions Expertise As Well As Enhanced Access to US,…
Leveraging decades of experience, Cardillo will help guide Synthetaic to shape the future of geospatial…
CHICAGO–(BUSINESS WIRE)–Addison Group Executive Vice President, Human Resources, Peg Buchenroth is recognized on SIA’s Diversity,…
IoT devices are prime targets for hackers staging denial-of-service attacks, making firmware updates, strong passwords, and 24/7 monitoring essential.
Digital science and AI can cut drug development to one-tenth of the usual decade-long timeline, but cybersecurity and ethics remain critical challenges.
Recruitment to Resume Imminently Top-line Results Expected in Mid-2024 PETACH TIKVA, Israel, May 22, 2023 (GLOBE…
Recruitment to Resume Imminently Top-line Results Expected in Mid-2024 PETACH TIKVA, Israel, May 22, 2023 (GLOBE…
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…